Chris Lehman

Role
Chief Executive Officer at Collabrity
Location
Point Roberts, WA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Chris Lehman

I am a strategic and forward-thinking C-level executive who has helped to enable…

Experience

  1. Chief Executive Officer

    Collabrity

    Aug 2022 — Present

    For early-stage therapeutic biotech CEO\'s seeking top-tier yet affordable C-level executive support in fundraising and operations that will stay with you from inception to exit, Collabrity has innovated a leveraged strategic consulting model that is uniquely suited to the needs of our clients. Quality, affordability, and continuity for private therapeutic biotech company CEOs worldwide – I look forward to scheduling a time soon to further explore the exceptional value that Collabrity would bring to your fundraising efforts and operations. Our DNA is from “inside the tent”. We see your challenges from the perspective of CFOs, CBOs, and COOs - and CXO combinations thereof – because those have been our roles. We have spent the bulk of our careers on senior leadership teams as employees of therapeutic biotech companies. Our imprinting experiences were not in consulting, auditing, or investment banking. While our approach may be consultative and our hours less than full-time according to your needs, we can be the corner office partner of CEOs - because our executive suite offices were always a short walk away. Executive quality standards. We come from listed companies, biotech unicorns, and companies backed by top-tier life sciences venture capital firms. We bring to our clients best-in-class analytics, practices, and performance based on executive experience. Yet we are affordable because we are leveraged. As executives, we have spent our careers forming, leading and monitoring G&A and R&D teams to efficiently perform the work of turning transformative research insights into FDA-approved therapies that serve patients. Because of our deep operational experience, we have deconstructed and re-imagined the needs of early-stage biotech CEO’s from scratch and realized that under our guidance we can ensure the bulk of a partnering or financing campaign can be delegated to our highly trained, lower-cost Associates so that we can pass on the economies to our clients.

Education

  • Yale University

    BA cum laude, History

  • Stanford University Graduate School of Business

    Certificate, Completed nationally recognized Advanced Negotiation Program

  • University of California, Berkeley, Haas School of Business

    MBA, Entrepreneurship

Skills

  • Negotiation
  • Corporate Development
  • Biopharmaceuticals
  • Project Management
  • Cross-Functional Team Leadership
  • Due Diligence
  • Life Sciences
  • Executive Management
  • Competitive Intelligence
  • Financial Modeling
  • Oncology
  • Budgeting
  • Management Consulting
  • Pharmaceutical Industry
  • Licensing
  • Drug Development
  • Lifesciences
  • Market Development
  • Start-Ups
  • Competitive Analysis
  • Business Strategy
  • Finance
  • Business Alliances
  • Strategy
  • Cash Flow Forecasting
  • Valuation
  • Business Development
  • Financial Analysis
  • R&D
  • Clinical Development
  • Commercialization
  • Business Planning
  • Strategic Partnerships
  • Management
  • Venture Capital
  • Microsoft Excel
  • Biotechnology
  • Mergers & Acquisitions
  • Cancer
  • Strategic Planning

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Chris Lehman — Chief Executive Officer at Collabrity in Point Roberts, WA, US | Unifers